The UK Ophthalmic Drugs Market growth continues to thrive as regenerative medicine and cell therapy research open new therapeutic frontiers. With retinal degenerative diseases causing irreversible vision loss, researchers are exploring stem cell-derived retinal pigment epithelium transplants, gene editing for inherited conditions, and optogenetic vision restoration. Growing investments in...